Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time?

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):97-8. doi: 10.1016/j.jaip.2013.11.010.

Authors

Robert A Wood¹, Hugh A Sampson²

Affiliations

¹ Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: rwood@jhmi.edu.
² Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.

PMID: 24565776
DOI: 10.1016/j.jaip.2013.11.010

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adrenergic Agonists / therapeutic use*
Allergens / administration & dosage*
Anaphylaxis / drug therapy*
Arachis / adverse effects*
Desensitization, Immunologic / methods*
Epinephrine / therapeutic use*
Humans
Peanut Hypersensitivity / therapy*
Plant Proteins / administration & dosage*

Substances

Adrenergic Agonists
Allergens
Plant Proteins
Epinephrine